← Product Code [LRJ](/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/LRJ) · K961044 # NOVIGUARD QUICK DRY (K961044) _Dr. Novis Smith & Co., Inc. · LRJ · Jul 3, 1997 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/LRJ/K961044 ## Device Facts - **Applicant:** Dr. Novis Smith & Co., Inc. - **Product Code:** [LRJ](/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/LRJ.md) - **Decision Date:** Jul 3, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.6890 - **Device Class:** Class 1 - **Review Panel:** General Hospital ## Indications for Use Noviguard is a general purpose disinfectant and is intended to be used on non-critical devices, dental and medical equipment, surfaces such as wheelchairs, dental chairs and medical beds in health care facilities. ## Device Story Noviguard Quick Dry is a surface disinfectant formulated with phenol and ortho-phenyl phenol complexed with oleyltrimethylenediamine (Adogen 572) and polyvinylpyrrolidone (PVP) in an ethanol solvent. Upon application, the ethanol evaporates rapidly, leaving a thin, high-concentration phenolic film on the surface. This film provides a rapid initial kill of microorganisms and acts as a slow-release barrier for sustained disinfection. The device is intended for use by healthcare personnel on non-critical medical and dental equipment and surfaces to maintain a disinfected state after initial cleaning. It offers a wider spectrum of antimicrobial activity and longer-lasting protection compared to standard phenolic disinfectants. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Disinfectant solution containing phenol, ortho-phenyl phenol, oleyltrimethylenediamine (Adogen 572), and PVP in ethanol. Operates via chemical disinfection and formation of a residual antimicrobial film. Liquid form for surface application. No electronic components or software. ## Regulatory Identification A general purpose disinfectant is a germicide intended to process noncritical medical devices and equipment surfaces. A general purpose disinfectant can be used to preclean or decontaminate critical or semicritical medical devices prior to terminal sterilization or high level disinfection. Noncritical medical devices make only topical contact with intact skin. ## Predicate Devices - Lysol ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} JUN 20 '97 10:54AM PEACOCK LABS.PHILA.PA 19143 P.3/6 6-2 DR NOVIS SMITH & CO 1034 Laurel Oak Road Voorhees, NJ 08043 800-668-4482 PA (215) 627-3200 Fax (215) 922-1211 510(k) SUMMARY Prepared June 19, 1997 This 510(k) Summary for Noviguard Quick Dry has been prepared by Dr. Novis Smith who can be reached at the place of business noted in the letterhead and is the contact person. Noviguard Quick Dry is a specially formulated general purpose disinfectant based on phenol and ortho phenyl phenol which are complexed reversibly with a oleyltrimethylenediamine (Adogen 572) and another basic polymer(PVP) to form a thin film which contains a high concentration of the phenolic disinfectant when dried. (This permits the use of low levels of phenol in the use solution to be about 0.5% yet when the very thin film dries the percentage of phenol is about 25% as the complex.) The phenol is retained and escapes as if in a slow release situation over week or more. the higher molecular weight components which also are disinfectants remain and maintain an effective disinfecting barrier. This whole formulation is dissolved in ethanol which permits the solution to dry within seconds for fast even application to surfaces. Ethanol does not attack most normally found surfaces in homes or hospitals. We claim equivalence to Lysol which is based on just ortho-phenyl phenol. These are both products with at use concentrations of about 1% or less of active components. Both have been designed for the hospital and the home for primary disinfecting of exposed surfaces against a wide range of organisms. Noviguard Quick Dry is intended to be used as a general purpose disinfectant after cleanup has been accomplished or on surfaces nominally clean to maintain these surfaces in a disinfected state. This is achieved by using two phenols which act more rapidly and have a wider number of organisms which Noviguard would be effective against and in combination with the film forming polymer and oleyl trimethylenediamine. This unique combination permits the application of small amounts of disinfectant to surfaces and yet obtains maximum effectiveness since a rapid effective kill occurs and a longer lasting disinfecting action is maintained. K 96 10 44 JUL - 3 1997 {1} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Dr. Novis Smith President Dr. Novis Smith & Company, Incorporated 701 Haddon Avenue Collingswood, New Jersey 08108 JUL - 3 1997 Re: K961044 Trade Name: Noviguard Quick Dry Regulatory Class: Unclassified Product Code: LRJ Dated: May 20, 1997 Received: May 21, 1997 Dear Dr. Smith: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 {2} Page 2 - Mr. Smith through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Timothy A. Ulatowski Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3} 3-5 STATEMENT OF INDICATIONS FOR USE 510(k) Number (if known): K961044 Device Name: Noviguard Quick Dry Indications For Use: Noviguard is a general purpose disinfectant and is intended to be used on non-critical devices, dental and medical equipment, surfaces such as wheelchairs, dental chairs and medical beds in health care facilities. Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of Dental, Infection Control, and General Hospital Devices 510(k) Number K961044 Prescription Use ☐ OR Over-the-Counter Use ☑ --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/LRJ/K961044](https://fda.innolitics.com/submissions/HO/subpart-g%E2%80%94general-hospital-and-personal-use-miscellaneous-devices/LRJ/K961044) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com